HLB Life Science Co. Ltd Cash Flow Reinvestment Rate
HLB Life Science Co. Ltd cash flow reinvestment rate. HLB Life Science Co. Ltd (067630) has a Cash Flow Reinvestment Rate of 2.19x as of March 2023, reinvesting ₩7.79 Billion (capex ₩3.52 Billion plus investments ₩-4.27 Billion) from operating cash flow of ₩3.55 Billion. See how financially flexible is HLB Life Science Co. Ltd to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of HLB Life Science Co. Ltd (2012–2020)
Cash flow reinvestment rate of HLB Life Science Co. Ltd from 2012 to 2020. Historical reinvestment intensity for HLB Life Science Co. Ltd across 4 annual periods. Explore how well can HLB Life Science Co. Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
HLB Life Science Co. Ltd Cash Flow Reinvestment Rate by Year (2012–2020)
HLB Life Science Co. Ltd cash flow reinvestment rate by year from 2012 to 2020. Year-by-year capital reinvestment analysis for HLB Life Science Co. Ltd. For the full cash flow conversion analysis, see 067630 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 12.05x | ₩24.21 Billion | ₩2.01 Billion | ₩8.41 Billion | ▲ +9080.6% |
| 2014 | 0.13x | ₩1.37 Billion | ₩10.43 Billion | ₩236.21 Million | ▲ +651.5% |
| 2013 | 0.02x | ₩51.48 Million | ₩2.95 Billion | ₩51.48 Million | ▼ -97.3% |
| 2012 | 0.66x | ₩9.18 Billion | ₩13.97 Billion | ₩9.18 Billion | — |